Crossmark

Kidney cancer PDOXs reveal patient‐specific pro‐malignant effects of antiangiogenics and its molecular traits

Crossref DOI link: https://doi.org/10.15252/emmm.201911889

Published Online: 2020-11-05

Published Print: 2020-12-07

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Moserle, Lidia

Pons, Roser

Martínez‐Lozano, Mar

Jiménez‐Valerio, Gabriela A

Vidal, August

Suárez, Cristina

Trilla, Enrique

Jiménez, José

de Torres, Inés

Carles, Joan

Senserrich, Jordi

Aguilar, Susana

Palomero, Luis

Amadori, Alberto

Casanovas, Oriol https://orcid.org/0000-0002-4298-3995
Funding

Funding for this research was provided by:

Ministerio de Economía, Industria y Competitividad, Gobierno de España (SAF2016‐79347‐R)

Associazione Italiana per la Ricerca sul Cancro (IG#14032)
License Information

Version of Record valid from 2020-11-05
More Information

Publication History

Received: 2019-12-10

Accepted: 2020-09-25

Published: 2020-11-05